We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Demonstrates State-Of-The-Art ESR Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022

ALCOR Scientific (Smithfield, RI, USA) is demonstrating its innovative diagnostic instruments and medical devices for the healthcare industry at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany. More...

At MEDICA 2022, ALCOR is presenting iSED, a 20-position, fully automated ESR analyzer that produces results in 20 seconds using just 100µL of sample taken directly from the primary EDTA tube. This small sample volume makes the iSED ideal for pediatric and low volume samples. Primary tube sampling ensures sample and result traceability and decreases biohazard risk to the user. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS.

ALCOR is also demonstrating the miniiSED, a single position, fully automated ESR analyzer that uses the same technology as the iSED in a smaller footprint. The miniiSED produces results in just 15 seconds using only 100 µL of sample taken directly from the primary EDTA tube. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS. With the small sample volume and fast turnaround time in a minimal footprint, the miniiSED is the ideal ESR analyzer for small hospital laboratories, emergency rooms, specialty testing laboratories and POLs.

Related Links:
ALCOR Scientific


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.